A demonstration in Rome by supporters of stem-cell therapy snarled traffic and forced the lower of house of Parliament to shut down Monday. The protesters claim a potential therapy involving the removal of bone-marrow stem cells from a ...
Tags: stem-cell, treatment, demonstration, Rome, snarls, traffic
Merck has secured priority review status from the US Food and Drug Administration (FDA) for its new drug application (NDA) for an investigational intravenous (IV) solution formulation of its antifungal agent, Noxafil (posaconazole), ...
Scientists from the medical sciences division at Penn State University have discovered that a compound in fish oil appears to target leukemia stem cells and could lead to a cure for the disease. The compound is a natural extract from EPA, ...
Italy-based Gentium and Link Healthcare announced that defibrotide has been designated as an orphan drug for the treatment of hepatic veno-occlusive disease (VOD). The sponsor of Defibrotide is Link Healthcare, Gentium's exclusive ...
Tags: Gentium, Orphan Drug
The Brain & Behavior Research Foundation (BBRF) (formerly known as NARSAD, the National Alliance for Research on Schizophrenia and Depression), under the direction of president and CEO Dr Jeffrey Borenstein, has announced the latest ...
Tags: Narsad, BBRF, investigator, award
Green formulations are a focal theme of the upcoming Asia-Pacific edition of the Sustainable Cosmetics Summit. It will take place in Hong Kong on 11-13 November. The summit will have dedicated sessions and workshops on green materials and ...
Tags: Green Formulations
IntelliCell BioSciences, a US-based regenerative medicine firm using adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels found in adipose tissue, has received notice that its patent application has been ...
RTI Surgical, a surgical implant company, has announced the first US implantation of its map3 cellular allogeneic bone graft in a foot and ankle procedure. Map3 cellular allogeneic bone graft is based on Athersys' licensed multipotent ...
Using plasmas, sealed plastic bags can be modified at atmospheric pressure so that human cells can adhere to and reproduce on their walls. Cell culture bags of this kind are an important aid for research and clinical purposes and may ...
Clinical-stage company OncoMed Pharmaceuticals has announced the issuance of US patent for methods of treating cancer with its antibody vantictumab (OMP-18R5) through 2029. Targeting and inhibiting the Wnt pathway, Vantictumab was ...
Tags: Vantictumab, OncoMed
The European Commission has granted orphan drug designation to BrainStorm Cell Therapeutics’ stem cell therapy NurOwn to treat Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease. NurOwn consists of autologous ...
Tags: Orphan Drug, Medicine
Boston Biomedical has relocated its headquarters to Cambridge, Massachusetts with the opening of a new 64,000ft2 facility, in a bid to advance its efforts in discovering next generation of targeted cancer therapeutics. Commenting on the ...
Tags: Boston, Cambridge, Biomedical
The FDA has approved the use of Astellas Pharma US' Mycamine (micafungin sodium) for injection to treat pediatric patients aged four months and more with candidemia, acute disseminated candidiasis, Candida peritonitis and abscesses, ...
Stemline Therapeutics' SL-401 has won orphan drug designation from the Food and Drug Administration (FDA) for the treatment of aggressive hematologic malignancy blastic plasmacytoid dendritic cell neoplasm (BPDCN). With an orphan drug ...
Tags: Stemline Therapeutic, Orphan Drug
Sangamo BioSciences has received a $6.4m strategic partnership grant from the California Institute for Regenerative Medicine (CIRM) for the development of ZFP Therapeutic for Beta-thalassemia. The application of its zinc finger nuclease ...
Tags: Sangamo, ZFG Therapeutic